News

The trial will evaluate the value of genetic testing on reducing adverse events associated with Warfarin therapy. GenMark, a provider of automated, multiplex molecular diagnostic testing systems, said

Tesetaxel is a new taxane that is administered by mouth as a capsule. The drug was developed with a goal of maintaining high antitumor activity while eliminating infusion

Horizons-AMI trial was sponsored by the Cardiovascular Research Foundation (CRF) with grant support from Boston Scientific and The Medicines Company. Horizons-AMI is a randomised trial to compare the

The merger brings $42m in assets to Biomagnetics, including land to expand, when necessary, to meet future production levels to fill anticipated market demands. Biomagnetics president Clayton Hardman

Amgen said that the lamellae result from the interaction of the formulation with glass vials over the shelf life of the product. Epogen and Procrit are indicated for

The primary objectives of the study are to determine the safety, tolerance and pharmacokinetic (PK) properties of CX-4945 in multiple myeloma patients and to select the appropriate dose

Belgium-based Helvoet Pharma said that the plant, which will manufacture components for primary packaging of parenteral pharmaceutical and diagnostic drugs, is the first one outside of Europe and

As per the terms of the deal, Warner Chilcott assumes rights to solely promote and develop Enablex for the US. While, Novartis retains the rights to Darifenacin worldwide,

AMT-080 has shown efficacy in studies of a preclinical model of DMD. The proof of concept studies demonstrated that AMT’s technology resulted in functional dystrophin synthesis in both